Advanced Search
Shen Wenbin, Zhu Shuchai, Gao Hongmei, Li Juan, Su Jingwei, Liu Zhikun, Li Youmei, Wan Jun. Toxic Effect and Long-term Survival of Three Dimensional Conformal High-dose Radiotherapy for Non- small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 577-581. DOI: 10.3971/j.issn.1000-8578.2012.05.021
Citation: Shen Wenbin, Zhu Shuchai, Gao Hongmei, Li Juan, Su Jingwei, Liu Zhikun, Li Youmei, Wan Jun. Toxic Effect and Long-term Survival of Three Dimensional Conformal High-dose Radiotherapy for Non- small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 577-581. DOI: 10.3971/j.issn.1000-8578.2012.05.021

Toxic Effect and Long-term Survival of Three Dimensional Conformal High-dose Radiotherapy for Non- small Cell Lung Cancer

More Information
  • Received Date: August 01, 2011
  • Revised Date: November 17, 2011
  • Objective To compare the long term survival and side effects of the high-dose radiotherapy with the convention radiotherapy for locally advanced non-small cell lung cancer(NSCLC),and to analysis the prognostic factors. Methods From Jan,2000 to Jan,2004,75 patients underwent high-dose radiotherapy(HRT) and 83 patients received conventional radiotherapy(CRT) in non-small cell lung cancer were analyzed.The clinical evaluation of the patients in the recent 3 months after radiotherapy were carried out according RECIST criteria.The toxicity reaction to the patients were graded.SPSS11.5 software was used for statistical analysis. Results The two groups had the same variable.For all patients,the overall response rate(CR + PR) was 80.4%,and the 1-,3- and 5- year survival rates were 44.9 %,19.0% and 11.7%,respectively.There were no statistics significance between HRT group and CRT group.For all patients,the 1-,3- and 5-years local control rate was 76.8%,48.1% and 40.5%,respectively.There were statistics significance between HRT group and CRT group(χ2=3.80,P=0.041).The multivariate analysis showed that the maximum diameter of tumor,chemotherapy,treatment time and short-term curative effect were independent prognostic factors.Compared HRT group with CRT group,the treatment time was shorter(χ2=3.93,P=0.047),and the short-term curative effect was better(χ2=9.649,P=0.022).But,there were no statistics significance between the two groups in the rate of radiation injury. Conclusion The high-dose radiotherapy has a good long effective in the treatment of NSCLC.The treatment time was shorter and the side effects were not more.
  • [1]
    Xiu X,Deng X,Li MY,et al.Clinical analysis of 3DCRT for early stage non-small cell lung cancer[J].Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi,2007,27(1):73-5.[修霞,邓湘,李明昱,等.早期非小细胞肺癌三维适形放射治疗的疗效[J].中华放射医学与防护杂志,2007,27(1):73-5.]
    [2]
    Onimaru R,Fujino M,Yamazaki K,et al.Steep dose-response relationship for stage I non-small-celllung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy[J].Int J Radiat Oncol Biol Phys,2008,70(2):374-81.
    [3]
    Fritz P,Kraus HJ,Blaschke T,et al.Stereotactic,high single-dose irradiation of stage I non-small cell lung cancer(NSCLC) using four-dimensional CT scans for treatment planning[J].LungCancer,2008,60(2):193-9.
    [4]
    Zhou TC,Lin XD,Cheng Z.Three dimensional conformal hypofractionated hige-dose radiotherapycombined with chemotherapy for stage Ⅲ non-small cell lung cancer[J].Zhong Liu Fang Zhi YanJiu,2004,31(8):498-500.[周同冲,林晓丹,成拯.大分割三维适形放疗联合化疗治疗Ⅲ期非小细胞肺癌疗效分析[J].肿瘤防治研究,2004,31(8):498-500.]
    [5]
    Tang Q,Yang KY,Wang P,et al.Three dimensional conformal hypofractionated high dose radiotherapycombined with low dose density chemotherapeutic regimen for 72 cases of stage Ⅲ non-small cell lungcancer[J].Zhong Liu Fang Zhi Yan Jiu,2006,33(6):453-4.[唐求,杨坤禹,王鹏,等.大分割三维适形放疗联合低剂量密集式化疗治疗III 期非小细胞肺癌72 例临床分析[J].肿瘤防治研究,2006,33(6):453-4.]
    [6]
    Etiz D,Marks LB,Zhou SM,et al.Influence of tumor volume on survival in patients irradiated fornon-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2002,53(4):835-46.
    [7]
    Rengan R,Rosenzweig KE,Venkatraman E,et al.Improved local control with higher doses ofradiation in large-volume stage III non-small-cell lung cancer[J].Int J Radiat Oncol BiolPhys,2004,60(3):741-7.
    [8]
    Perez CA,Stanley K,Grundy G,et al.Impact of irradiation technique and tumor extent in tumorcontrol and survival of patients with unresectable non-oat carcinoma of the lung:report by theRadiation Therapy Oncology Group [J].Cancer,1982,50(6):1091-9.
    [9]
    Belderbos JS,Heemsbergen WD,De Jaeger K,et al.Final results of a Phase I/II dose escalationtrial in non-small cell lung cancer using three-dimensional conformal radiotherapy[J].Int J RadiatOncol Biol Phys,2006,66(1):126-34.
    [10]
    Choi N,Baumann M,Flentjie M,et al.Predictive factors in radiotherapy for non-small celllung cancer:present status[J].Lung Cancer,2001,31(1):43-56.
    [11]
    Mehta M,Scrimger R,Mackie R,et al.A new approach to dose escalation in non-small cell lungcancer[J].Int J Radiat Oncol Biol Phys,2001,49(1):23-33.
    [12]
    Chemotherapy in non-small cell lung cancer:a Meta analysis using update data on individualpatients from 52 randomized clinical trials Non-small cell lung cancer collaborative group[J].BMJ,1995,311(7010):899-909.
    [13]
    Fournel P,Robinet G,Thomas P,et al.Randomized phase Ⅲ trial of sequential chemoradiotherapycompared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer:GroupeLyon-Saint-Etienne d’Oncologie Thoracique-Groupe Franais de Pneumo-Cancérologie NPC 95-01 Study[J].J Clin Oncol,2005,23(25):5910-7.
    [14]
    Uitterhoeve AL,Belderbos JS,Koolen MG,et al.Toxicity of high-dose radiotherapy combined withdaily cisplatin in non-small cell lung cancer:results of the EORTC 08912 phase I/II study[J].Eur JCancer,2000,36(5),592-600.

Catalog

    Article views (2588) PDF downloads (588) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return